Cardiovascular Surgery News and Research

RSS

Sorin introduces new VascuClear device for clinicians

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular devices, is proud to announce the introduction of its VascuClear Endoscopic Vessel Harvesting (EVH) system to replace the existing EVH product offering.

2 May 2011

CryoLife's BioGlue Surgical Adhesive launched in Japan

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011.

25 Apr 2011

FDA approves St. Jude Medical's Trifecta valve for stented aortic valve replacement

St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.

21 Apr 2011

Loyola enrolls patients in clinical trial for open-heart valve replacement surgery

Loyola University Hospital is enrolling patients in a clinical trial that offers an alternative to traditional open-heart surgery for patients who need new aortic heart valves.

20 Apr 2011

Less-invasive catheter-based aortic valve replacement as safe and effective as open surgery

Less-invasive catheter-based aortic valve replacement has a similar one-year survival as open valve-replacement surgery for patients at high risk for surgery.

5 Apr 2011

IASIS enters definitive agreement to purchase 78.2% interest in St. Joseph Medical Center

IASIS Healthcare LLC today announced that it has entered into a definitive agreement to purchase a 78.2% interest in St. Joseph Medical Center, a 792-bed facility in downtown Houston, Texas.

19 Mar 2011

Medtronic launches Contour 3D Annuloplasty Ring for treatment of tricuspid valve disease

Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.

14 Mar 2011

Efficient medical treatments to be showcased at SIR's 36th Annual Scientific Meeting

The Society of Interventional Radiology will feature minimally invasive scientific advances and new discoveries in treating a host of diseases at its 36th Annual Scientific Meeting March 26–31 at McCormick Place (West) in Chicago, Ill. The theme of the meeting is "IR Rising: Leading Image-guided Medicine," chosen to reflect interventional radiology's continued revolutionizing of modern medicine.

5 Mar 2011

Ziehm Imaging launches next generation hybrid Vision RFD mobile C-arm

Ziehm Imaging has launched a new generation of the Ziehm Vision RFD mobile C-arm. Offering outstanding imaging and a liquid cooling system which allows it to be used over an almost unlimited period of time, the new version is an attractive choice for hybrid ORs.

3 Mar 2011

Aggressive treatment of T3 and T4 NSCLC with induction chemoradiotherapy may improve survival

Researchers from Boston University School of Medicine (BUSM) have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. These findings currently appear on-line in the Journal of Thoracic and Cardiovascular Surgery.

1 Mar 2011

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON annual meeting in Scottsdale, Arizona.

16 Feb 2011

Aesthetic and dental surgical procedures show greater than average growth

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, standouts in surgical procedures in terms of growth over the next five years are going to be dental implant, facial injectable, optical coherence tomography (OCT) catheter, spinal nonfusion implant, and percutaneous heart valve procedures in North America.

15 Feb 2011

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

21 Jan 2011

Drug-coated stents hold promise for treatment of clogged leg arteries

Drug-coated stents hold promise as a safe and lasting solution for the treatment of clogged leg arteries, suggest two-year results of the Zilver PTX Trial being presented at the 23rd annual International Symposium on Endovascular Therapy (ISET). Blocked leg arteries are a symptom of peripheral arterial disease (PAD), which affects 8 to 12 million Americans.

18 Jan 2011

Top ten advances in cardiovascular, stroke research in 2010

Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research recognized by the American Heart Association/American Stroke Association.

22 Dec 2010

Silence provides year-end update on trading and offer-period

Silence Therapeutics plc, a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today provides a year-end update on trading and the offer-period.

21 Dec 2010

Positive results from large, multi-center Canadian trial with On-X Prosthetic Heart Valve

On-X® Life Technologies, Inc., today announced the publication of results of a large, prospective multi-center Canadian trial with the On-X® Prosthetic Heart Valve in the November issue of The Journal of Thoracic and Cardiovascular Surgery.1 According to the results of the report, "The On-X mechanical prosthesis provides favorable intermediate-term results with regard to major thromboembolism, hemorrhage and composites of valve-related complications."

15 Dec 2010

Methodist to develop national training center for treatment of cardiovascular disease

The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.

30 Nov 2010

Gore sponsors EVEResT Lunch Symposium

W. L. Gore & Associates is sponsoring the EVEResT (European Virtual Reality Endovascular Research Team) Lunch Symposium taking place on Friday, Nov. 19 from 12:00 to 1:00 p.m. at the VEITHsymposium in the Gramercy A room, second floor. The symposium will detail the evidence for simulation in medical training and in other fields. Companies will demonstrate how new simulation technologies are designed to enhance performance in endovascular procedures.

20 Nov 2010

New type of heart pump for infants born with univentricular circulation

Researchers have created a new type of heart pump inserted with a catheter to improve the survival rate for infants undergoing a series of surgeries to correct a deadly birth defect.

10 Nov 2010